Orthopedics Today reports on HSS study results presented at the Musculoskeletal Infection Society (MSIS) Annual Meeting by Andy O. Miller, MD, infectious disease specialist, on the impact of a previous infection with SARS-CoV-2 on primary elective total joint replacement.

HSS researchers focused on preoperative IgG antibody test results in 5,354 patients who were operated on between May 2020 to January 2021.

Dr. Miller explained, “While there were no differences with respect to age, sex or comorbidity indices, COVID-19 history patients were more likely to be Black, more likely to be Hispanic, to be obese and be anemic, and somewhat less likely to have a history of rheumatoid arthritis.”

He added, “Overall in-hospital complication rate was 0.4% with no significant difference between groups and zero complications in our COVID-19 history cohort.”

Read the full article at Healio.com/news/orthopedics.